• Explore /
  • Poster
  • / A phase II trial of lenvatinib plus toripalimab and hepatic arterial infusion chemotherapy as a first-line treatment for advanced hepatocellular carcinoma (LTHAIC study).

A phase II trial of lenvatinib plus toripalimab and hepatic arterial infusion chemotherapy as a first-line treatment for advanced hepatocellular carcinoma (LTHAIC study).

Abstract Video & Slides Poster

Authors

null

MinKe He

Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

MinKe He , Shi Ming , Zhicheng Lai , QiJiong Li

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT04044313

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4083)

DOI

10.1200/JCO.2021.39.15_suppl.4083

Abstract #

4083

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Yongkang Xu

First Author: Gong-Rang Chen

First Author: Patricio Eduardo Yanez

First Author: Yang-Kui Gu